Skip to content
HEMEXHEMEXHEMEX
  • Our Services
  • Partners
  • Customers
  • About us
    • Certifications
  • HGS
  • News
  • Contact us
Image of Brandon Garcia, HEMEX intern

Diversity Hemex Team

Meet Brandon García, our newest intern at HEMEX

New Year's resolutions can be a powerful way to make positive changes in life and [...]

Continue reading →

Investment Press Release

Hera Biotech acquires Scailyte’s endometriosis diagnostic assets

Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]

Continue reading →

Clinical Development Innovation Investment Press Release

Resistell recruits first patients for international clinical study

Resistell recruits first patients for international clinical study

Continue reading →

Innovation Investment Press Release

Reaching for the stars – ASPIVIX receives 510(k) clearance of Carevix™ from the U.S. FDA

HEMEX is proud to announce that our portfolio company ASPIVIX has received 510(k) clearance of [...]

Continue reading →

Innovation Investment Press Release

Moving forward fast – ASPIVIX is finishing the 2022 with a new investment and a generous grant

We are thrilled to share that HEMEX is part of the investment consortium financing the [...]

Continue reading →
Press Release, Regulatory

HEMEX is ISO 9001:2015 and ISO 13485:2016 Quality Management System certified

Posted on April 28, 2022February 18, 2025 by Juan Ruiz
Image of supporting columns

This milestone shows the devotion of our QA team to ensuring HEMEX’s high standards and commitment to quality. Achieving this certification was one of the milestones we wished to accomplish in 2022.

Continue reading →
Posted in Press Release, Regulatory  |  Tagged clinical, clinical development, Start-Up, switzerland
Clinical Development, Collaboration, Innovation, Regulatory

Welcome Hi-D Imaging!

Posted on April 11, 2020July 24, 2023 by Brayan Arboleda
Continue reading →
Posted in Clinical Development, Collaboration, Innovation, Regulatory  |  Tagged clinical development, fundraising, innovation, investor, regulatory, seed, start-ups Leave a comment

Contact us

info@hemex.ch

Flag of Switzerland Icon

Headquarters

HEMEX AG
Kasernenstrasse 30
4410 Liestal

Switzerland

Subsidiaries

HEMEX Germany GmbH
c/o Loeba Treuhand GmbH
Wallbrunnstr. 24
79539 Loerrach
Germany

HEMEX Benelux BV
Vital Decosterstraat 16
3000 Leuven
Belgium

HEMEX Global Services S.A.S.
Carrera 43A Nro 19 17
Medellín, Colombia

Copyright 2011-2024 © HEMEX AG

HEMEX ® and the collaborative M® are registered trademarks of HEMEX AG.

Data Protection Officer Contact (24/7/365)

+49 1512 568 48 92
DPO@hemex-germany.de

Privacy Policy (EN | DE)

Quality Policy

Follow us:

linkedin icon

Contact us

info@hemex.ch

Follow us:

Headquarters

HEMEX AG
Kasernenstrasse 30
4410 Liestal

Switzerland

Subsidiaries

HEMEX Germany GmbH
c/o Loeba Treuhand GmbH,
Wallbrunnstr. 24
79539 Loerrach
Germany

HEMEX Benelux BV
Vital Decosterstraat 16
3000 Leuven
Belgium

HEMEX Global Services S.A.S.
Carrera 43A Nro 19 17
Medellín, Colombia

Copyright 2011-2024 © HEMEX AG

HEMEX ® and the collaborative M® are registered trademarks of HEMEX AG.

Data Protection Officer contact (24/7/365)

+49 1512 568 48 92
DPO@hemex-germany.de

Privacy Policy (EN | DE)

Quality Policy

Flag of Switzerland Icon
  • Our Services
  • Partners
  • Customers
  • About us
    • Certifications
  • HGS
  • News